LAUSR

Introduction/Background Shoulder pain is the most common complication of post-stroke, which occur up to 60% patients with post-stroke. The aim of our research is to study the effect botulinum toxin type A and triamcinolone for shoulder pain on patients with post-stroke. Material and method Seventy-five patients with shoulder pain on post-stroke patients were randomly divided into three groups based on difference of injection (A:BoNT-A, B: triamcinolone, C: saline). Each group was injected once with ultrasound guidance. All groups received therapeutic exercise up to 4 weeks. The Evaluation of Fugl-Meyer assessment (FMA), Visual Analogue Scale (VAS) and pain-free range of motion (ROM) were recorded for pain and quality of life at baseline and end of 4th week after injection. Results The FMA of upper-limb were significantly improved in group A and group B patients between baseline and end of 4th week (P  Conclusion The all treatments can significantly reduce shoulder pain and recovery function in patients with stroke, but BoNT-A combined with physical therapy seems to affect better for such patients.